BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1426033)

  • 1. Calpain concentration is elevated although net calcium-dependent proteolysis is suppressed in dystrophin-deficient muscle.
    Spencer MJ; Tidball JG
    Exp Cell Res; 1992 Nov; 203(1):107-14. PubMed ID: 1426033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDGF-receptor concentration is elevated in regenerative muscle fibers in dystrophin-deficient muscle.
    Tidball JG; Spencer MJ; St Pierre BA
    Exp Cell Res; 1992 Nov; 203(1):141-9. PubMed ID: 1426037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calpains are activated in necrotic fibers from mdx dystrophic mice.
    Spencer MJ; Croall DE; Tidball JG
    J Biol Chem; 1995 May; 270(18):10909-14. PubMed ID: 7738032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calpain translocation during muscle fiber necrosis and regeneration in dystrophin-deficient mice.
    Spencer MJ; Tidball JG
    Exp Cell Res; 1996 Aug; 226(2):264-72. PubMed ID: 8806430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ measurements of calpain activity in isolated muscle fibres from normal and dystrophin-lacking mdx mice.
    Gailly P; De Backer F; Van Schoor M; Gillis JM
    J Physiol; 2007 Aug; 582(Pt 3):1261-75. PubMed ID: 17510188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteolysis results in altered leak channel kinetics and elevated free calcium in mdx muscle.
    Turner PR; Schultz R; Ganguly B; Steinhardt RA
    J Membr Biol; 1993 May; 133(3):243-51. PubMed ID: 8392585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation of SH3 and cysteine-rich domain 3 and junctophilin 1 from dihydropyridine receptor in dystrophin-deficient muscles.
    Ashida Y; Himori K; Tokuda N; Naito A; Yamauchi N; Takenaka-Ninagawa N; Aoki Y; Sakurai H; Yamada T
    Am J Physiol Cell Physiol; 2022 Sep; 323(3):C885-C895. PubMed ID: 35912995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of a calpastatin transgene in mdx muscle reduces dystrophic pathology.
    Spencer MJ; Mellgren RL
    Hum Mol Genet; 2002 Oct; 11(21):2645-55. PubMed ID: 12354790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of calpain and proteasome inhibition on Ca2+-dependent proteolysis and muscle histopathology in the mdx mouse.
    Briguet A; Erb M; Courdier-Fruh I; Barzaghi P; Santos G; Herzner H; Lescop C; Siendt H; Henneboehle M; Weyermann P; Magyar JP; Dubach-Powell J; Metz G; Meier T
    FASEB J; 2008 Dec; 22(12):4190-200. PubMed ID: 18728218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of contractile activity on muscle damage in the dystrophin-deficient mdx mouse.
    McArdle A; Edwards RH; Jackson MJ
    Clin Sci (Lond); 1991 Apr; 80(4):367-71. PubMed ID: 1851074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin metabolism in dystrophin-deficient MDX mouse muscle.
    McArdle A; Foxley A; Edwards RH; Jackson MJ
    Biochem Soc Trans; 1991 Apr; 19(2):177S. PubMed ID: 1889562
    [No Abstract]   [Full Text] [Related]  

  • 12. Accumulation of calcium by normal and dystrophin-deficient mouse muscle during contractile activity in vitro.
    McArdle A; Edwards RH; Jackson MJ
    Clin Sci (Lond); 1992 Apr; 82(4):455-9. PubMed ID: 1315657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice.
    Montgomery E; Pennington C; Isales CM; Hamrick MW
    Anat Rec A Discov Mol Cell Evol Biol; 2005 Sep; 286(1):814-22. PubMed ID: 16078270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic reversion/suppression of the mouse mdx phenotype in vivo.
    Hoffman EP; Morgan JE; Watkins SC; Partridge TA
    J Neurol Sci; 1990 Oct; 99(1):9-25. PubMed ID: 2250176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced expression of regucalcin in young and aged mdx diaphragm indicates abnormal cytosolic calcium handling in dystrophin-deficient muscle.
    Doran P; Dowling P; Donoghue P; Buffini M; Ohlendieck K
    Biochim Biophys Acta; 2006 Apr; 1764(4):773-85. PubMed ID: 16483859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the normal content of sulfhydryl groups attributable to sparing from dystrophic pathology in dystrophin-deficient muscles?
    Niebrój-Dobosz I; Fidziańska A; Glinka Z; Hausmanowa-Petrusewicz I
    Folia Neuropathol; 2002; 40(3):143-50. PubMed ID: 12572920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related changes in muscle calcium content in dystrophin-deficient mdx mice.
    Reeve JL; McArdle A; Jackson MJ
    Muscle Nerve; 1997 Mar; 20(3):357-60. PubMed ID: 9052816
    [No Abstract]   [Full Text] [Related]  

  • 18. Calpains and muscular dystrophies.
    Tidball JG; Spencer MJ
    Int J Biochem Cell Biol; 2000 Jan; 32(1):1-5. PubMed ID: 10661889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myotubes from transgenic mdx mice expressing full-length dystrophin show normal calcium regulation.
    Denetclaw WF; Hopf FW; Cox GA; Chamberlain JS; Steinhardt RA
    Mol Biol Cell; 1994 Oct; 5(10):1159-67. PubMed ID: 7865881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subproteomics analysis of Ca+-binding proteins demonstrates decreased calsequestrin expression in dystrophic mouse skeletal muscle.
    Doran P; Dowling P; Lohan J; McDonnell K; Poetsch S; Ohlendieck K
    Eur J Biochem; 2004 Oct; 271(19):3943-52. PubMed ID: 15373840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.